JP2007529530A5 - - Google Patents

Download PDF

Info

Publication number
JP2007529530A5
JP2007529530A5 JP2007503993A JP2007503993A JP2007529530A5 JP 2007529530 A5 JP2007529530 A5 JP 2007529530A5 JP 2007503993 A JP2007503993 A JP 2007503993A JP 2007503993 A JP2007503993 A JP 2007503993A JP 2007529530 A5 JP2007529530 A5 JP 2007529530A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
group
unsubstituted
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007503993A
Other languages
English (en)
Japanese (ja)
Other versions
JP4918476B2 (ja
JP2007529530A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/008429 external-priority patent/WO2005089269A2/en
Publication of JP2007529530A publication Critical patent/JP2007529530A/ja
Publication of JP2007529530A5 publication Critical patent/JP2007529530A5/ja
Application granted granted Critical
Publication of JP4918476B2 publication Critical patent/JP4918476B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2007503993A 2004-03-16 2005-03-15 増殖性疾患を治療するための置換フェノキシ−及びフェニルチオ−誘導体 Expired - Fee Related JP4918476B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55400804P 2004-03-16 2004-03-16
US60/554,008 2004-03-16
PCT/US2005/008429 WO2005089269A2 (en) 2004-03-16 2005-03-15 Substituted phenoxy- and phenylthio- derivatives for treating proliferative disorders

Publications (3)

Publication Number Publication Date
JP2007529530A JP2007529530A (ja) 2007-10-25
JP2007529530A5 true JP2007529530A5 (cg-RX-API-DMAC7.html) 2008-05-08
JP4918476B2 JP4918476B2 (ja) 2012-04-18

Family

ID=34994233

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007503993A Expired - Fee Related JP4918476B2 (ja) 2004-03-16 2005-03-15 増殖性疾患を治療するための置換フェノキシ−及びフェニルチオ−誘導体

Country Status (13)

Country Link
US (1) US7932242B2 (cg-RX-API-DMAC7.html)
EP (2) EP1740530B8 (cg-RX-API-DMAC7.html)
JP (1) JP4918476B2 (cg-RX-API-DMAC7.html)
KR (1) KR101274524B1 (cg-RX-API-DMAC7.html)
AU (2) AU2005222947B2 (cg-RX-API-DMAC7.html)
CA (1) CA2559187C (cg-RX-API-DMAC7.html)
DK (1) DK1740530T3 (cg-RX-API-DMAC7.html)
EA (2) EA200901236A1 (cg-RX-API-DMAC7.html)
ES (1) ES2609084T3 (cg-RX-API-DMAC7.html)
HU (1) HUE030786T2 (cg-RX-API-DMAC7.html)
IL (1) IL176836A (cg-RX-API-DMAC7.html)
NZ (1) NZ549962A (cg-RX-API-DMAC7.html)
WO (1) WO2005089269A2 (cg-RX-API-DMAC7.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004289281C1 (en) 2003-11-14 2011-12-08 Onconova Therapeutics, Inc. Alpha, beta-Unsaturated sulfoxides for treating proliferative disorders
US20090306207A1 (en) * 2005-01-05 2009-12-10 Reddy M V Ramana Treatment of Drug-Resistant Proliferative Disorders
WO2006104668A2 (en) * 2005-03-11 2006-10-05 Temple University - Of The Commonwealth System Of Higher Education Composition and methods for the treatment of proliferative diseases
CA2663375A1 (en) 2006-09-15 2008-03-20 Onconova Therapeutics, Inc. Activated cytotoxic compounds for attachment to targeting molecules for the treatment of mammalian disease conditions
WO2009094172A2 (en) * 2008-01-22 2009-07-30 Araim Pharmaceuticals, Inc. Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
JP5734869B2 (ja) * 2008-12-16 2015-06-17 オンコノバ・セラピューティックス・インコーポレーテッド ヒトにおける細胞毒性物質の有害作用に対する治療レジメンの有効性を決定する方法
US8735620B2 (en) * 2008-12-17 2014-05-27 Epr Pharmaceuticals Pvt. Ltd Processes for preparing (E)-styrylbenzylsulfone compounds and uses thereof for treating proliferative disorders
US9730913B2 (en) 2011-10-13 2017-08-15 The Johns Hopkins University High affinity beta lactamase inhibitors
CA2885217C (en) 2012-09-20 2019-10-08 Temple University - Of The Commonwealth System Of Higher Education Substituted alkyl diaryl derivatives, methods of preparation and uses
US10052339B2 (en) 2014-03-21 2018-08-21 Bodybio Inc. Methods and compositions for treating symptoms of diseases related to imbalance of essential fatty acids
WO2015142500A2 (en) 2014-03-21 2015-09-24 Bodybio Inc. Compositions and methods for treating addiction
US10383831B2 (en) 2015-08-03 2019-08-20 Temple University—Of the Commonwealth System of Higher Education 2,4,6-trialkoxystryl aryl sulfones, sulfonamides and carboxamides, and methods of preparation and use
EP3596043B1 (en) 2017-03-15 2025-12-03 Lunella Biotech, Inc. Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
CN112694499B (zh) * 2020-12-14 2023-09-19 上海科技大学 一种交联剂及其制备与在质谱交联技术中的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865867A (en) * 1967-06-19 1975-02-11 Monsanto Co Meta-bifunctional benzenes
US3975435A (en) * 1974-03-06 1976-08-17 Givaudan Corporation Substituted cinnamanilides
JPS5720942B2 (cg-RX-API-DMAC7.html) * 1974-04-18 1982-05-04
JPS51126127A (en) * 1975-03-11 1976-11-04 Ricoh Co Ltd Coupling component for diazotype photosensitive materials
CA1213229A (en) 1982-04-12 1986-10-28 Gary S. David Antibodies having dual specificities, their preparation and uses therefor
FR2559646B1 (fr) * 1984-02-21 1986-07-18 Centre Nat Rech Scient Procede de reduction du taux de lignine dans les vegetaux et nouvelles compositions pour sa mise en oeuvre
US5169939A (en) 1985-05-21 1992-12-08 Massachusetts Institute Of Technology & Pres. & Fellows Of Harvard College Chimeric antibodies
CA1282069C (en) 1985-09-12 1991-03-26 Damon L. Meyer Antibody complexes of hapten-modified diagnostic or therapeutic agents
ZA869613B (en) * 1985-12-23 1987-08-26 Ciba Geigy Ag Aromatic thioethers
US5202238A (en) 1987-10-27 1993-04-13 Oncogen Production of chimeric antibodies by homologous recombination
US5204244A (en) 1987-10-27 1993-04-20 Oncogen Production of chimeric antibodies by homologous recombination
US5091313A (en) 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5292867A (en) 1988-11-16 1994-03-08 Tanox Biosystems, Inc. Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin
US5658897A (en) * 1996-04-08 1997-08-19 Allergan Cyclopentane(ene) heptanoic or cyclopentane(ene) heptenoic acid, 2-hydrocarbyl phosphinyloxyalkyl or phosphonamidoalkyl as therapeutic agents
ATE284386T1 (de) 1997-10-03 2004-12-15 Univ Temple Styrolsulfone als antikrebsmittel
US6548553B2 (en) 1997-10-03 2003-04-15 Temple University-Of The Commonwealth System Of Higher Education Styryl sulfone anticancer agents
CZ20012294A3 (cs) * 1998-12-22 2001-12-12 F. Hoffmann-La Roche Ag Sulfonamidové hydroxamáty
US6201154B1 (en) 1999-03-31 2001-03-13 Temple University-Of The Commonwealth Of Higher Education Z-styryl sulfone anticancer agents
WO2000059495A1 (en) * 1999-04-02 2000-10-12 Temple University - Of The Commonwealth System Of Higher Education (e)-styryl sulfone anticancer agents
US6762207B1 (en) 1999-04-02 2004-07-13 Temple University - Of The Commonwealth System Of Higher Education (E)-styryl sulfone anticancer agents
US6117364A (en) 1999-05-27 2000-09-12 Nalco/Exxon Energy Chemicals, L.P. Acid corrosion inhibitor
KR100796851B1 (ko) 1999-06-16 2008-01-22 템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 사이클록시게나아제-2의 억제제로서 1-(4-설파밀아릴)-3-치환형-5-아릴-2-피라졸린
CA2375511A1 (en) 1999-06-16 2000-12-21 Temple University - Of The Commonwealth System Of Higher Education (z)-styryl acetoxyphenyl sulfides as cyclooxygenase inhibitors
US6665973B1 (en) 1999-09-27 2003-12-23 Vladimir Georgiev Peev Striker trigger mechanism for automatic and semi-automatic firearms
US6767926B1 (en) * 1999-10-12 2004-07-27 Temple University - Of The Commonwealth System Of Higher Education Method for protecting normal cells from cytotoxicity of chemotherapeutic agents
US6541475B2 (en) 2000-04-14 2003-04-01 Temple University - Of The Commonwealth System Of Higher Education α, β-unsaturated sulfones for treating proliferative disorders
US6486210B2 (en) * 2000-04-14 2002-11-26 Temple University—Of the Commonwealth System of Higher Education Substituted styryl benzylsulfones for treating proliferative disorders
DE60115265T2 (de) * 2000-09-19 2006-08-10 Lee, Moses, Holland Zusammensetzungen und verfahren zur verwendung achiraler analoge von cc-1065 und den duocarmycinen
CA2424884C (en) 2000-10-05 2009-12-15 E. Premkumar Reddy Substituted (e)-styryl benzylsulfones for treating proliferative disorders
WO2002067913A1 (en) 2001-02-27 2002-09-06 Temple University-Of The Commonwealth System Of Higher Education (z)-styrylbenzylsulfones and pharmaceutical uses thereof
US6667346B2 (en) * 2001-02-28 2003-12-23 Temple University - Of The Commonwealth System Of Higher Education Method for protecting cells and tissues from ionizing radiation toxicity with α, β unsaturated aryl sulfones
DK1379508T3 (da) * 2001-02-28 2011-01-03 Univ Temple N-(aryl)-2arylethensulfonamider og terapeutiske anvendelser deraf
DE10113027A1 (de) * 2001-03-17 2002-09-19 Wella Ag 3-(2,5-Diaminophenyl)-acrylamid-Derivate und diese Verbindungen enthaltende Färbemittel
US7078407B2 (en) * 2001-11-23 2006-07-18 Korea Research Institute Of Chemical Technology 4-hydroxycinnamamide derivatives as antioxidants and pharmaceutical compositions containing them
IL163608A0 (en) 2002-02-28 2005-12-18 Univ Temple Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders
NZ535232A (en) * 2002-02-28 2007-05-31 Univ Temple Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
JP2006512306A (ja) * 2002-08-29 2006-04-13 テンプル・ユニバーシティ−オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション アリール及びヘテロアリールプロペンアミド、それらの誘導体並びにそれらの治療用途
AU2004289281C1 (en) * 2003-11-14 2011-12-08 Onconova Therapeutics, Inc. Alpha, beta-Unsaturated sulfoxides for treating proliferative disorders
US8143453B2 (en) * 2005-02-25 2012-03-27 Temple University—Of the Commonwealth System of Higher Education Unsaturated sulfides, sulfones, sulfoxides and sulfonamides synthesis

Similar Documents

Publication Publication Date Title
JP7685551B2 (ja) O-置換セリン誘導体の製造方法
JP6092513B2 (ja) フルオレン化合物
EP1753775B1 (en) Process for preparing acyclic hcv protease inhibitors
TWI302835B (en) 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease
KR20070117664A (ko) 매크로사이클릭 화합물의 제조방법
JP4877225B2 (ja) ポリオキシアルキレン誘導体
CN1312817A (zh) 截尾海兔肽15衍生物
CA2952541A1 (en) Pyridazones and triazinones for the treatment and prophylaxis of hepatitis b virus infection
JP2007535474A (ja) 複合補体カスケードインヒビター
WO2007102392A1 (ja) Mmp-13選択的阻害剤
TWI871182B (zh) 用於fapi合成的中間體及其製備方法和應用
CN1168673A (zh) 具有n-末端磺酰基或氨基磺酰基的新颖二肽对-脒基苄基酰胺
CN105658670A (zh) 肽-低聚尿素嵌合化合物及其使用方法
CN120957761A (zh) 具有靶向作用的偶联物及其制备方法和用途
JP2005530809A (ja) フェニルシクロヘキシルプロパノールアミン誘導体、その製造法、およびその治療的適用
CN109134481B (zh) 一种取代吡咯色原酮类化合物或其药学上可接受的盐及其制备方法和应用
HU226688B1 (hu) Szubsztituált 1,3-diaril-2-piridin-2-il-3-(piridin-2-il-amino)-propanol-származékok, eljárás az elõállításukra, alkalmazásuk és az ezeket a vegyületeket tartalmazó gyógyszerkészítmények
JP2018501268A (ja) チゾキサニドホスフェート及びアルカンスルホネート並びにその医薬用途
CN104788361A (zh) 5-氮杂螺[2.4]庚烷-6-甲酸衍生物的合成方法
JPH082860B2 (ja) ペプチド合成用新規カップリング剤
KR20200142529A (ko) 치환된 피리디논-함유 트리사이클릭 화합물의 제조 방법
JP4800558B2 (ja) 環状ペプチド誘導体
WO1999032459A1 (en) Chymase inhibitors
CN1162318A (zh) 新活性肽及其制备
JPWO2002016404A1 (ja) 環状ペプチド誘導体